⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MTVA News
MetaVia Inc. Common Stock
Presenting on Emerging Growth Conference 90 Day 2 on February 26; Register to live stream
globenewswire.com
CRGO
OESX
CLNN
UMAC
AEMD
MTVA
ASPI
USAU
ZENA
USEG
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
globenewswire.com
CRGO
OESX
UMAC
CLNN
MTVA
ASPI
AEMD
ZENA
USEG
USAU
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
prnewswire.com
MTVA
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
prnewswire.com
MTVA
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
prnewswire.com
MTVA
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
prnewswire.com
MTVA
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
prnewswire.com
MTVA
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
prnewswire.com
MTVA
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
prnewswire.com
MTVA
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
prnewswire.com
MTVA